Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
HUINNO logo — Leading the digital healthcare market.

HUINNO

Leading the digital healthcare market.

Founded 2014 Korea South Korea South 48 employees Series C Total: $56.80B AI, Hardware +3

General Information

Company Name HUINNO
Founded Year 2014
Location Korea South Korea South +1
Founders / Decision Makers
Team member
Employees 48
Industries AI, Hardware, Health Care +2
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with HUINNO. To contact HUINNO, visit huinno.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About HUINNO

HUINNO is a leading player in the digital healthcare market, specializing in developing wearable solutions for cardiac monitoring. Established in 2014, the company offers smartwatches and patches equipped with cutting-edge AI-based cloud analysis software, enabling easy and convenient diagnosis and treatment of cardiac diseases such as arrhythmia, atrial fibrillation, and hypertension. The digital healthcare startup has successfully established partnerships with Seoul National University Hospital, Korea University Hospital, and Yuhan Corp, demonstrating its strong presence in the industry. One of HUINNO's key technologies, MEMO AI, is an AI-based biosignal analysis solution renowned for its ability to analyze various biosignals with exceptional precision. With the capability to analyze ECG readings with a precision of 97% (significantly surpassing conventional algorithms), MEMO AI greatly enhances medical institutions' ability to increase diagnosis precision and improve the efficiency of medical services. The company's second technology allows for the convenient measurement and monitoring of various biosignals over extended periods, with devices equipped with ultra-low power technology ensuring extended usage without recharging. In December 2021, HUINNO secured a KRW43.50B Series C investment with participation from notable investors such as FuturePlay, Meritz Securities, NH Investment & Securities, DAOL Investment, and Yuhan Corporation. This latest investment highlights the confidence of prominent investors in HUINNO's innovative offerings and its potential for further growth and expansion. With its focus on revolutionizing the digital healthcare market and a strong track record of partnerships and investments, HUINNO positions itself as a key player in the industry.

Taxonomy: digital healthcare, wearable technology, cardiac monitoring, AI-based analysis, arrhythmia, atrial fibrillation, hypertension, cloud analysis software, partnerships with hospitals/clinics, biometric sensors, ultra-low power technology, diagnosis and treatment, startup

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 5
Investor Investor Investor
•••• •••• 		28 Dec 2021
Series B •••••• 5
Investor Investor Investor
•••• •••• 		21 Dec 2020
Series A •••••• - 02 Mar 2020
Series A •••••• - 16 Aug 2019
Seed Round •••••• - 27 Jun 2014

FAQ About HUINNO

Leading the digital healthcare market.
HUINNO was founded in 2014.
HUINNO is headquartered in Korea South.
HUINNO operates in the following industries: AI, Hardware, Health Care, Mobile, Machine Learning.
HUINNO has approximately 48 employees.
HUINNO has completed 5 funding rounds, raising a total of $56.80B. The latest funding stage is Series C.

We're actively collecting intelligence on HUINNO.

Source: BounceWatch company record for HUINNO, https://bouncewatch.com/company/huinno, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes